Because T cells rely on tightly controlled levels of these metabolites to support activation and proliferation, loss of SIRT7 results in metabolic dysregulation, impaired expansion and activation, and the promotion of an exhausted phenotype that compromises anti-tumor immunity (Figure 3) [70]. This evidence concerns the gene SIRT7 and neoplasm.